Pfizer buys GBT, maker of sickle cell disease treatment; Carlyle CEO Kewsong Lee steps down abruptly

Carlyle's CEO Kewsong quits.

8 August 2022•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.